Australia's ALS falls most in more than a year on weak FY24 outlook
** Shares of ALS Ltd ALQ.AX fall as much as 6.8% to
A$12/795, posting their biggest intraday pct fall since March 7,
2023
** The testing services provider says FY24 NPAT guidance
range will be at the lower end of the previously stated range of
A$310 mln ($202.49 mln)- A$325 mln
** Says corporate and interest costs are to be slightly
higher in FY24
** Shares hit their lowest level since March 7
** Stock up ~7% YTD, as of last close
($1 = 1.5309 Australian dollars)
(Reporting by Echha Jain in Bengaluru)
((Echha.jain@thomsonreuters.com))
Recent news on ALS
See all newsMorningstar maintains fair value price for Australia's ALS on demand for mineral testing
Jefferies positive on Australia's ALS Ltd reaffirming FY27 outlook
Brief: ALS Ltd Remains On Track To Deliver High Single Digit Organic Revenue Growth & Margin Improvement Consistent With FY26
Australia's ALS rises on positive trading update
Australia's ALS jumps as brokerages raise earnings estimate on commodities boost